Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
Patent
·
OSTI ID:904221
- Durham, NC
- Los Alamos, NM
The present invention relates, generally, to a polyvalent immunogen and, more particularly, to a method of inducing neutralizing antibodies against HIV and to a polyvalent immunogen suitable for use in such a method.
- Research Organization:
- Univ. of California (United States); Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- W-7405-ENG-36
- Assignee:
- Duke University (Durham, NC); The Regents of the University of Calforinia (Oakland, CA)
- Patent Number(s):
- 7,153,509
- Application Number:
- 10/289,228
- OSTI ID:
- 904221
- Country of Publication:
- United States
- Language:
- English
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen
|
journal | January 1998 |
HIV Vaccine Development at Duke University Medical Center
|
journal | January 2000 |
HIV Type 1 V3 Region Primer-Induced Antibody Suppression Is Overcome by Administration of C4-V3 Peptides as a Polyvalent Immunogen
|
journal | February 1995 |
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses
|
journal | August 2000 |
Similar Records
Polyvalent immunogen
Polyvalent immunogen
Antibody evolution immunogens
Patent
·
Tue Feb 06 00:00:00 EST 2007
·
OSTI ID:904221
+1 more
Polyvalent immunogen
Patent
·
Tue Mar 27 00:00:00 EDT 2007
·
OSTI ID:904221
Antibody evolution immunogens
Patent
·
Tue Dec 01 00:00:00 EST 2020
·
OSTI ID:904221
+9 more